Lupus clinical trials in New Jersey
6 studies for Lupus are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, West Long Branch
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Rutgers New Jersey Medical School, Newark
- Arthritis Rheumatic And Back Disease Associates, Voorhees Township
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07438496Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Astera Cancer Care, East Brunswick
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Sahni Rheumatology & Therapy, West Long Branch
RecruitingObservational study
Ages 16 and older · All sexes · Updated Sep 3, 2026 · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Hackensack Meridian Health, Hackensack
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT05799378From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.